{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T11:01:30Z","timestamp":1789297290632,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["grant 2021-02091"],"award-info":[{"award-number":["grant 2021-02091"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["grant 2024-06176"],"award-info":[{"award-number":["grant 2024-06176"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"VINNOVA","doi-asserted-by":"publisher","award":["2024-00460"],"award-info":[{"award-number":["2024-00460"]}],"id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["101043985"],"award-info":[{"award-number":["101043985"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Heteroresistance (HR) is an antibiotic resistance phenotype characterized by the presence of rare resistant subpopulations (frequency\u2009\u2248\u200910\n                    <jats:sup>\u22127<\/jats:sup>\n                    to 10\n                    <jats:sup>\u22124<\/jats:sup>\n                    ) within a main susceptible bacterial population. During antibiotic exposure, these subpopulations can be enriched and cause treatment failure. Standard antibiotic susceptibility testing (AST) often fails to detect HR, and the current gold-standard population analysis profile (PAP) test is labor-intensive and time-consuming. We present a digital phenotyping approach combining droplet microfluidics with image texture to detect HR from clinical isolates, including Gram-negative (\n                    <jats:italic>Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii<\/jats:italic>\n                    ) and Gram-positive (\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    ) bacteria isolated from bloodstream infections. Our method achieves detection at subpopulation frequencies as low as 10\n                    <jats:sup>\u22126<\/jats:sup>\n                    in 12 to 30\u2009h, depending on bacterial species, which is faster than the PAP test, together with single-cell resolution and high-throughput. This computationally assisted microfluidic platform enables rapid and accurate identification of HR, representing a step toward targeted antibiotic therapy in critical infections.\n                  <\/jats:p>","DOI":"10.1038\/s41746-026-02808-x","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:33:47Z","timestamp":1780126427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Droplet microfluidics with image texture quantification for detection of rare antibiotic-resistant subpopulations from bloodstream infections"],"prefix":"10.1038","volume":"9","author":[{"given":"Sagar N.","family":"Agnihotri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Fatsis-Kavalopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Vikdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Windhager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin A.","family":"Corbat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan I.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tenje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"2808_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi, M. et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet 404, 1199\u20131226 (2024).","journal-title":"Lancet"},{"key":"2808_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33659-1","volume":"13","author":"V Kandavalli","year":"2022","unstructured":"Kandavalli, V., Karempudi, P., Larsson, J. & Elf, J. Rapid antibiotic susceptibility testing and species identification for mixed samples. Nat. Commun. 13, 6215 (2022).","journal-title":"Nat. Commun."},{"key":"2808_CR3","doi-asserted-by":"publisher","unstructured":"Angella, C.-K. et al. Use of the accelerate pheno system for identification and antimicrobial susceptibility testing of pathogens in positive blood cultures and impact on time to results and workflow. J. Clin. Microbiol. 56, https:\/\/doi.org\/10.1128\/jcm.01166-17 (2017).","DOI":"10.1128\/jcm.01166-17"},{"key":"2808_CR4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1177\/2472630317727721","volume":"22","author":"KP Smith","year":"2017","unstructured":"Smith, K. P., Richmond, D. L., Brennan-Krohn, T., Elliott, H. L. & Kirby, J. E. Development of MAST: a microscopy-based antimicrobial susceptibility testing platform. SLAS Technol. 22, 662\u2013674 (2017).","journal-title":"SLAS Technol."},{"key":"2808_CR5","doi-asserted-by":"publisher","unstructured":"Wistrand-Yuen, P. et al. A multiplex fluidic chip for rapid phenotypic antibiotic susceptibility testing. mBio. 11, https:\/\/doi.org\/10.1128\/mbio.03109-19 (2020).","DOI":"10.1128\/mbio.03109-19"},{"key":"2808_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s42003-021-02052-x","volume":"4","author":"C Pereira","year":"2021","unstructured":"Pereira, C., Larsson, J., Hjort, K., Elf, J. & Andersson, D. I. The highly dynamic nature of bacterial heteroresistance impairs its clinical detection. Commun. Biol. 4, 521 (2021).","journal-title":"Commun. Biol."},{"key":"2808_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41579-019-0218-1","volume":"17","author":"DI Andersson","year":"2019","unstructured":"Andersson, D. I., Nicoloff, H. & Hjort, K. Mechanisms and clinical relevance of bacterial heteroresistance. Nat. Rev. Microbiol. 17, 479\u2013496 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"2808_CR8","doi-asserted-by":"crossref","unstructured":"Liu, H. et al. Carbapenem-resistant Gram-negative bacteria exhibiting clinically undetected cefiderocol heteroresistance leads to treatment failure in a murine model of infection. Front. Microbiol. 16, 1496514 (2025).","DOI":"10.3389\/fmicb.2025.1496514"},{"key":"2808_CR9","doi-asserted-by":"crossref","unstructured":"Band, V. I. et al. Carbapenem-Resistant Klebsiella pneumoniae exhibiting clinically undetected colistin heteroresistance leads to treatment failure in a Murine model of infection. mBio. 9, 10\u20131128 (2018).","DOI":"10.1128\/mBio.02448-17"},{"key":"2808_CR10","doi-asserted-by":"publisher","unstructured":"Band V. I. & Satola, S. W. Colistin heteroresistance is largely undetected among carbapenem-resistant enterobacterales in the United States. mBio 12, https:\/\/doi.org\/10.1128\/mbio.02881-20 (2021).","DOI":"10.1128\/mbio.02881-20"},{"key":"2808_CR11","doi-asserted-by":"publisher","first-page":"e1007726","DOI":"10.1371\/journal.ppat.1007726","volume":"15","author":"VI Band","year":"2019","unstructured":"Band, V. I. & Weiss, D. S. Heteroresistance: a cause of unexplained antibiotic treatment failure? PLoS Pathog. 15, e1007726 (2019).","journal-title":"PLoS Pathog."},{"key":"2808_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.10.013","volume":"55","author":"X Jia","year":"2020","unstructured":"Jia, X. et al. Heteroresistance to cefepime in Pseudomonas aeruginosa bacteraemia. Int. J. Antimicrob. Agents 55, 105832 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"2808_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.101010","volume":"6","author":"G Heyman","year":"2025","unstructured":"Heyman, G. et al. Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study. Lancet Microbe 6, 101010 (2025).","journal-title":"Lancet Microbe"},{"key":"2808_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41564-018-0342-0","volume":"4","author":"H Nicoloff","year":"2019","unstructured":"Nicoloff, H., Hjort, K., Levin, B. R. & Andersson, D. I. The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification. Nat. Microbiol. 4, 504\u2013514 (2019).","journal-title":"Nat. Microbiol."},{"key":"2808_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48233-0","volume":"15","author":"H Nicoloff","year":"2024","unstructured":"Nicoloff, H., Hjort, K., Andersson, D. I. & Wang, H. Three concurrent mechanisms generate gene copy number variation and transient antibiotic heteroresistance. Nat. Commun. 15, 3981 (2024).","journal-title":"Nat. Commun."},{"key":"2808_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","volume":"22","author":"WR Miller","year":"2024","unstructured":"Miller, W. R. & Arias, C. A. ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics. Nat. Rev. Microbiol. 22, 598\u2013616 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"2808_CR17","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","volume":"25","author":"H Sati","year":"2025","unstructured":"Sati, H. et al. The WHO bacterial priority pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect. Dis. 25, 1033\u20131043 (2025).","journal-title":"Lancet Infect. Dis."},{"key":"2808_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/jac\/dkab461","volume":"77","author":"J Howard-Anderson","year":"2022","unstructured":"Howard-Anderson, J. et al. Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study. J. Antimicrob. Chemother. 77, 793\u2013798 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"2808_CR19","first-page":"e00333","volume":"12","author":"YJ Hyun","year":"2024","unstructured":"Hyun, Y. J. et al. Risk factors for vancomycin treatment failure in heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia. Microbiol. Spectr. 12, e00333\u201324 (2024).","journal-title":"Microbiol. Spectr."},{"key":"2808_CR20","doi-asserted-by":"publisher","first-page":"dlae146","DOI":"10.1093\/jacamr\/dlae146","volume":"6","author":"RK Shields","year":"2024","unstructured":"Shields, R. K. et al. Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections. Jac. Antimicrob. Resist. 6, dlae146 (2024).","journal-title":"Jac. Antimicrob. Resist."},{"key":"2808_CR21","first-page":"e05093","volume":"11","author":"K Hadas","year":"2023","unstructured":"Hadas, K. et al. Prevalence and clinical consequences of colistin heteroresistance and evolution into full resistance in carbapenem-resistant acinetobacter baumannii. Microbiol. Spectr. 11, e05093\u201322 (2023).","journal-title":"Microbiol. Spectr."},{"key":"2808_CR22","first-page":"e01010","volume":"9","author":"J Jeongwoo","year":"2021","unstructured":"Jeongwoo, J. & Soo, K. K. Tigecycline heteroresistance and resistance mechanism in clinical isolates of Acinetobacter baumannii. Microbiol. Spectr. 9, e01010\u2013e01021 (2021).","journal-title":"Microbiol. Spectr."},{"key":"2808_CR23","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/s41564-019-0480-z","volume":"4","author":"VI Band","year":"2019","unstructured":"Band, V. I. et al. Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infection. Nat. Microbiol. 4, 1627\u20131635 (2019).","journal-title":"Nat. Microbiol."},{"key":"2808_CR24","first-page":"1506","volume":"75","author":"K Tan","year":"2020","unstructured":"Tan, K. et al. Prevalence of the carbapenem-heteroresistant phenotype among ESBL-producing Escherichia coli and Klebsiella pneumoniae clinical isolates. J. Antimicrob. Chemother. 75, 1506\u20131512 (2020).","journal-title":"J. Antimicrob. Chemother."},{"key":"2808_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cmi.2022.10.018","volume":"29","author":"M Roch","year":"2023","unstructured":"Roch, M., Sierra, R. & Andrey, D. O. Antibiotic heteroresistance in ESKAPE pathogens, from bench to bedside. Clin. Microbiol. Infect. 29, 320\u2013325 (2023).","journal-title":"Clin. Microbiol. Infect."},{"key":"2808_CR26","doi-asserted-by":"publisher","first-page":"dlae057","DOI":"10.1093\/jacamr\/dlae057","volume":"6","author":"A Babiker","year":"2024","unstructured":"Babiker, A. et al. Heteroresistance to piperacillin\/tazobactam in Klebsiella pneumoniae is mediated by increased copy number of multiple \u03b2-lactamase genes. Jac. Antimicrob. Resist. 6, dlae057 (2024).","journal-title":"Jac. Antimicrob. Resist."},{"key":"2808_CR27","doi-asserted-by":"publisher","first-page":"dlaf071","DOI":"10.1093\/jacamr\/dlaf071","volume":"7","author":"Q Zhang","year":"2025","unstructured":"Zhang, Q. et al. Overview of heteroresistance to multiple antibiotics in clinical Klebsiella pneumoniae isolates and combination therapeutic strategies. Jac. Antimicrob. Resist. 7, dlaf071 (2025).","journal-title":"Jac. Antimicrob. Resist."},{"key":"2808_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijantimicag.2017.10.014","volume":"51","author":"J He","year":"2018","unstructured":"He, J. et al. Heteroresistance to carbapenems in invasive Pseudomonas aeruginosa infections. Int. J. Antimicrob. Agents 51, 413\u2013421 (2018).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"2808_CR29","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1128\/JCM.43.5.2494-2496.2005","volume":"43","author":"P Nottasorn","year":"2005","unstructured":"Nottasorn, P., Gilat, L., Heidi, B. & B, T. R. Unstable vancomycin heteroresistance is common among clinical isolates of Methiciliin-Resistant Staphylococcus aureus. J. Clin. Microbiol. 43, 2494\u20132496 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"2808_CR30","doi-asserted-by":"publisher","first-page":"e3002457","DOI":"10.1371\/journal.pbio.3002457","volume":"22","author":"S Heidarian","year":"2024","unstructured":"Heidarian, S., Guliaev, A., Nicoloff, H., Hjort, K. & Andersson, D. I. High prevalence of heteroresistance in Staphylococcus aureus is caused by a multitude of mutations in core genes. PLoS Biol. 22, e3002457 (2024).","journal-title":"PLoS Biol."},{"key":"2808_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1128\/JCM.01128-10","volume":"49","author":"SW Satola","year":"2011","unstructured":"Satola, S. W., Farley, M. M., Anderson, K. F. & Patel, J. B. Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J. Clin. Microbiol. 49, 177\u2013183 (2011).","journal-title":"J. Clin. Microbiol."},{"key":"2808_CR32","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1128\/JCM.01435-10","volume":"49","author":"K Riederer","year":"2011","unstructured":"Riederer, K. et al. Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and Agar screening methods. J. Clin. Microbiol. 49, 2147\u20132150 (2011).","journal-title":"J. Clin. Microbiol."},{"key":"2808_CR33","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1039\/D2LC00394E","volume":"22","author":"W Postek","year":"2022","unstructured":"Postek, W., Pacocha, N. & Garstecki, P. Microfluidics for antibiotic susceptibility testing. Lab Chip 22, 3637\u20133662 (2022).","journal-title":"Lab Chip"},{"key":"2808_CR34","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1039\/b804911d","volume":"8","author":"JQ Boedicker","year":"2008","unstructured":"Boedicker, J. Q., Li, L., Kline, T. R. & Ismagilov, R. F. Detecting bacteria and determining their susceptibility to antibiotics by stochastic confinement in nanoliter droplets using plug-based microfluidics. Lab Chip 8, 1265\u20131272 (2008).","journal-title":"Lab Chip"},{"key":"2808_CR35","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1021\/acs.accounts.1c00729","volume":"55","author":"W Postek","year":"2022","unstructured":"Postek, W. & Garstecki, P. Droplet microfluidics for high-throughput analysis of antibiotic susceptibility in bacterial cells and populations. Acc. Chem. Res. 55, 605\u2013615 (2022).","journal-title":"Acc. Chem. Res."},{"key":"2808_CR36","doi-asserted-by":"publisher","first-page":"032010","DOI":"10.1063\/5.0255319","volume":"37","author":"SN Agnihotri","year":"2025","unstructured":"Agnihotri, S. N. et al. Dynamics of non-Newtonian agarose gel droplet formation in two-phase microfluidic systems. Phys. Fluids 37, 032010 (2025).","journal-title":"Phys. Fluids"},{"key":"2808_CR37","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1021\/acs.langmuir.9b03515","volume":"36","author":"SN Agnihotri","year":"2020","unstructured":"Agnihotri, S. N., Raveshi, M. R., Bhardwaj, R. & Neild, A. Microfluidic valves for selective on-chip droplet splitting at multiple sites. Langmuir 36, 1138\u20131146 (2020).","journal-title":"Langmuir"},{"key":"2808_CR38","doi-asserted-by":"publisher","first-page":"051304","DOI":"10.1063\/5.0267868","volume":"37","author":"SN Agnihotri","year":"2025","unstructured":"Agnihotri, S. N., Raveshi, M. R., Nosrati, R., Bhardwaj, R. & Neild, A. Droplet splitting in microfluidics: a review. Phys. Fluids 37, 051304 (2025).","journal-title":"Phys. Fluids"},{"key":"2808_CR39","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1039\/C6LC01435F","volume":"17","author":"HD Xi","year":"2017","unstructured":"Xi, H. D. et al. Active droplet sorting in microfluidics: a review. Lab Chip 17, 751\u2013771 (2017).","journal-title":"Lab Chip"},{"key":"2808_CR40","doi-asserted-by":"publisher","first-page":"034020","DOI":"10.1103\/PhysRevApplied.11.034020","volume":"11","author":"SN Agnihotri","year":"2019","unstructured":"Agnihotri, S. N., Raveshi, M. R., Bhardwaj, R. & Neild, A. Droplet breakup at the entrance to a bypass channel in a microfluidic system. Phys. Rev. Appl. 11, 034020 (2019).","journal-title":"Phys. Rev. Appl."},{"key":"2808_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1039\/D4LC00826J","volume":"25","author":"A Vafaie","year":"2025","unstructured":"Vafaie, A., Shahali, S., Raveshi, M. R., Nosrati, R. & Neild, A. Repeated pulses of ultrasound maintain sperm motility. Lab Chip 25, 16\u201327 (2025).","journal-title":"Lab Chip"},{"key":"2808_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23773-x","volume":"12","author":"MR Raveshi","year":"2021","unstructured":"Raveshi, M. R. et al. Curvature in the reproductive tract alters sperm\u2013surface interactions. Nat. Commun. 12, 3446 (2021).","journal-title":"Nat. Commun."},{"key":"2808_CR43","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1039\/D2LC00435F","volume":"22","author":"SN Agnihotri","year":"2022","unstructured":"Agnihotri, S. N. et al. Droplet microfluidics for functional temporal analysis and cell recovery on demand using microvalves: application in immunotherapies for cancer. Lab Chip 22, 3258\u20133267 (2022).","journal-title":"Lab Chip"},{"key":"2808_CR44","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.snb.2018.05.047","volume":"270","author":"F Lyu","year":"2018","unstructured":"Lyu, F. et al. Phenotyping antibiotic resistance with single-cell resolution for the detection of heteroresistance. Sens. Actuators B Chem. 270, 396\u2013404 (2018).","journal-title":"Sens. Actuators B Chem."},{"key":"2808_CR45","doi-asserted-by":"crossref","unstructured":"Scheler, O. et al. Droplet-based digital antibiotic susceptibility screen reveals single-cell clonal heteroresistance in an isogenic bacterial population. Sci. Rep. 10, 3282 (2020).","DOI":"10.1038\/s41598-020-60381-z"},{"key":"2808_CR46","doi-asserted-by":"publisher","first-page":"eadv4558","DOI":"10.1126\/sciadv.adv4558","volume":"11","author":"SN Agnihotri","year":"2025","unstructured":"Agnihotri, S. N., Fatsis-Kavalopoulos, N., Windhager, J., Tenje, M. & Andersson, D. I. Droplet microfluidics\u2013based detection of rare antibiotic-resistant subpopulations in Escherichia coli from bloodstream infections. Sci. Adv. 11, eadv4558 (2025).","journal-title":"Sci. Adv."},{"key":"2808_CR47","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1109\/TSMC.1973.4309314","volume":"3","author":"RM Haralick","year":"1973","unstructured":"Haralick, R. M., Shanmugam, K. & Dinstein, I. Textural features for image classification. IEEE Trans. Syst. Man Cybern. SMC 3, 610\u2013621 (1973).","journal-title":"IEEE Trans. Syst. Man Cybern. SMC"},{"key":"2808_CR48","doi-asserted-by":"crossref","unstructured":"Ma, H., Zhang, Y., Shen, R. & Jia, Y. Droplet-based microfluidics in single-bacterium analysis: advancements in cultivation, detection, and application. Biosensors (Basel). 15, 535 (2025).","DOI":"10.3390\/bios15080535"},{"key":"2808_CR49","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1039\/D2LC01095J","volume":"23","author":"W Wu","year":"2023","unstructured":"Wu, W. et al. Direct single-cell antimicrobial susceptibility testing of Escherichia coli in urine using a ready-to-use 3D microwell array chip. Lab Chip 23, 2399\u20132410 (2023).","journal-title":"Lab Chip"},{"key":"2808_CR50","doi-asserted-by":"publisher","first-page":"17853","DOI":"10.1021\/acs.analchem.2c03604","volume":"94","author":"W Wu","year":"2022","unstructured":"Wu, W. et al. All-in-one Escherichia coli viability assay for multi-dimensional detection of uncomplicated urinary tract infections. Anal. Chem. 94, 17853\u201317860 (2022).","journal-title":"Anal. Chem."},{"key":"2808_CR51","doi-asserted-by":"publisher","first-page":"1803559","DOI":"10.1002\/adfm.201803559","volume":"28","author":"W Wu","year":"2018","unstructured":"Wu, W. et al. A thermosetting oil for droplet-based real-time monitoring of digital pcr and cell culture. Adv. Funct. Mater. 28, 1803559 (2018).","journal-title":"Adv. Funct. Mater."},{"key":"2808_CR52","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1021\/acsami.0c21696","volume":"13","author":"W Wu","year":"2021","unstructured":"Wu, W., Zhang, S., Zhang, T. & Mu, Y. Immobilized droplet arrays in thermosetting oil for dynamic proteolytic assays of single cells. ACS Appl. Mater. Interfaces 13, 6081\u20136090 (2021).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2808_CR53","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1128\/AAC.01021-12","volume":"57","author":"CY Pil","year":"2013","unstructured":"Pil, C. Y. et al. Treatment duration for uncomplicated staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study. Antimicrob. Agents Chemother. 57, 1150\u20131156 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2808_CR54","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/cid\/ciaa210","volume":"72","author":"M Bonten","year":"2021","unstructured":"Bonten, M. et al. Epidemiology of Escherichia coli Bacteremia: a systematic literature review. Clin. Infect. Dis. 72, 1211\u20131219 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"2808_CR55","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.7717\/peerj.453","volume":"2","author":"S van der Walt","year":"2014","unstructured":"van der Walt, S. et al. scikit-image: image processing in Python. PeerJ 2, e453 (2014).","journal-title":"PeerJ"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02808-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02808-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02808-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:02:17Z","timestamp":1780131737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02808-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2808"],"URL":"https:\/\/doi.org\/10.1038\/s41746-026-02808-x","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors (S.N.A., N.F.K., M.T., and D.I.A.) are shareholders in the company Singular Diagnostics AB and have a pending patent PCT application PCT\/SE2025\/050186. The authors declare no other competing financial or non-financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"410"}}